Trials / Completed
CompletedNCT01939457
400mcg Sublingual Misoprostol as First Line Treatment
Introduction of 400mcg Sublingual Misoprostol as First Line Treatment in 11 Health Posts in Three Districts in Senegal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 641 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2013-09-11
- Last updated
- 2013-09-11
Locations
1 site across 1 country: Senegal
Source: ClinicalTrials.gov record NCT01939457. Inclusion in this directory is not an endorsement.